187 related articles for article (PubMed ID: 17130956)
1. [Treatment of neurocysticercosis: a review].
Nogales-Gaete J; Arriagada C; Salinas R
Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
[TBL] [Abstract][Full Text] [Related]
2. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P
Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931
[TBL] [Abstract][Full Text] [Related]
4. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Kaur S; Singhi P; Singhi S; Khandelwal N
Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
[TBL] [Abstract][Full Text] [Related]
6. Anticysticercal treatment and seizures in neurocysticercosis.
Singh G; Sander JW
Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Del Brutto OH; Roos KL; Coffey CS; García HH
Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
[TBL] [Abstract][Full Text] [Related]
10. Be careful while using albendazole/praziquantel in neurocysticercosis.
Garg RK; Uniyal R; Malhotra HS
Neurol India; 2017; 65(4):924-926. PubMed ID: 28681797
[No Abstract] [Full Text] [Related]
11. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
[TBL] [Abstract][Full Text] [Related]
12. Drug treatment of neurocysticercosis.
Garg RK
Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
[TBL] [Abstract][Full Text] [Related]
13. Intramedullary spinal neurocysticercosis treated successfully with medical therapy.
Ahmed S; Paul SP
J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507
[TBL] [Abstract][Full Text] [Related]
14. Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: a case report.
Rodríguez-Hidalgo R; Carpio A; Van den Enden E; Benítez-Ortiz W
BMC Neurol; 2019 Apr; 19(1):52. PubMed ID: 30943908
[TBL] [Abstract][Full Text] [Related]
15. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
Keiser PB; Nash TE
Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
[TBL] [Abstract][Full Text] [Related]
16. Determining better treatments for neurocysticercosis.
Singh G; White AC
Lancet Infect Dis; 2014 Aug; 14(8):658-659. PubMed ID: 24999156
[No Abstract] [Full Text] [Related]
17. Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.
de Almeida Leandro L; Fraga CM; de Souza Lino R; Vinaud MC
Parasitol Res; 2014 Apr; 113(4):1313-7. PubMed ID: 24481905
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Sotelo J; Jung H
Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
[TBL] [Abstract][Full Text] [Related]
19. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neurocysticercosis.
The Lancet Infectious Diseases
Lancet Infect Dis; 2014 Aug; 14(8):657. PubMed ID: 25056011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
